Prashant Singh

DDW attendees will have the opportunity to learn about recent developments in biomarker-discovery for FGID/DGBI and Neurogastroenterology…

Ageing seems to have a beneficial effect on irritable bowel syndrome (IBS) (Sperber et al. Gastroenterology 2021), and the odds of developing IBS are lower when age is above 50 years (Lovell & Ford CGH 2012). Older age may also affect symptom reporting and quality of life…

Ageing seems to have a beneficial effect on irritable bowel syndrome (IBS) (Sperber et al. Gastroenterology 2021), and the odds of developing IBS are lower when age is above 50 years (Lovell & Ford CGH 2012). Older age may also affect symptom reporting and quality of life…

SOCIETY: AGA The intestine is the largest immune organ and is also heavily innervated by intrinsic and extrinsic neurons. Emerging data show multiple modes of interaction between cells of the nervous system (neurons and glia) and immune cells that impact both intestinal health and disease processes…

Sucrose malabsorption and small intestinal bacterial overgrowth (SIBO) both have symptoms that overlap with common functional gastrointestinal disorders (FGID). These common symptoms include abdominal pain/cramping, bloating, and diarrhea…

INTRODUCTION: The current ‘step-down’ approach to implementing a low FODMAP diet (LFD) in which all 5 FODMAP groups are restricted presents significant practical challenges for patients, A ‘step-up’ approach has been proposed where only 1-2 FODMAP groups are initially restricted and further restric…

INTRODUCTION: There is a lack of data on the efficacy of dietary therapies by IBS subtype (IBS-D, IBS-C, and IBS-M)…

BACKGROUND: IBS is associated with microbial dysbiosis. It has been reported that populations of _Bifidobacterium_ and _Faecalibacterium_ are implicated in tryptophan (trp) metabolism and decreased in IBS…

INTRODUCTION: A diet low in FODMAPs (LFD) is only effective in 50-60% of patients with irritable bowel syndrome (IBS) and is restrictive, time-consuming, and carries the risk of nutritional deficiencies. Therefore, there is a need for novel dietary therapies for IBS…

TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

SOCIETY: AGA